Biogen cuts the price tag on its Alzheimer's drug in half

Biogen is slashing the price of its Alzheimer’s treatment in half months after it debuted to widespread criticism for an initial cost that could reach $56,000 annually.

Related Keywords

Cambridge ,Cambridgeshire ,United Kingdom ,Massachusetts ,United States ,Michel Vounatsos ,Brian Abrahams ,Japan Eisai Co ,European Medicines Agency ,Biogen Inc ,Business ,Health ,Ational ,Science Tech ,